A61P 39 - General protective or antinoxious agents

Patents for A61P 39 - General protective or antinoxious agents (19,019)
12/1999
12/08/1999	EP0962453A1 Histidine derivatives, process for their preparation and their uses
12/08/1999	EP0674631B1 Substituted pyrazoles as crf antagonists
12/08/1999	EP0600970B1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
12/08/1999	CN1237354A Health-care tea and its production method
12/08/1999	CN1237353A Body-perfuming tea preparation
12/07/1999	US5998460 Phenylcarbamates of (-)-eseroline, (-)-N1-noreseroline and (-)-N1-benzylnoreseroline: selective inhibitors of acetyl and butyrylcholinesterase, pharmaceutical compositions and method of use thereof
12/07/1999	CA1340839C Proteins and process for preparing them, dna sequences, antibodies and uses thereof, posvirus, altered or infected cells, pharmaceutical compositions useful for the prevention of schistosomosis and uses thereof as an agent with a glutathion-s-transferase activity
12/02/1999	WO1999061427A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999	WO1999061031A1 Treatment of c. difficile toxin b associated conditions
12/02/1999	CA2333537A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999	CA2321927A1 Treatment of c. difficile toxin b associated conditions
12/01/1999	EP0960193A1 ISOLATION AND CLONING OF THE HUMAN hARSA-I GENE AND USES THEREOF
12/01/1999	EP0959886A1 Triaryl substituted imidazoles as glucagon antagonists
11/1999
11/30/1999	US5994413 Pressing, extraction
11/30/1999	US5994409 Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
11/30/1999	US5994325 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
11/30/1999	US5994127 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
11/25/1999	WO1999059404A1 Coenzyme q10 compositions for organ protection during perfusion
11/25/1999	CA2348636A1 Coenzyme q10 compositions for organ protection during perfusion
11/25/1999	CA2272833A1 Novel histidine derivatives, process for its preparation and uses thereof
11/24/1999	EP0959074A2 Substituted pyrazoles as CRF antagonists
11/24/1999	EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/24/1999	CN1046723C Tetracyclic compounds, pharmaceutical containing them and its use
11/23/1999	US5990285 Catalytic antibodies against cocaine
11/23/1999	US5989557 Process for extracting polyphenol fractions of tea and compositions produced therewith
11/17/1999	EP0956859A1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same
11/17/1999	EP0956019A1 Novel therapeutic application of a thienycyclohexylamine derivative
11/17/1999	CN1235518A Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical use
11/17/1999	CN1046512C Mercaptoacetylamide disulfide derivatives, preparation thereof and medicinal composition containing the same
11/16/1999	US5985895 2-naphthamide derivatives and their therapeutic applications
11/11/1999	WO1999056737A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999	WO1999043791A9 Diisopropyl fluorophosphatase and the utilization and production thereof
11/11/1999	CA2331364A1 Arylhydrocarbon receptor ligand antagonists
11/10/1999	EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999	EP0954302A1 Therapeutic methods and compositions involving isoflavones
11/10/1999	CN1234737A Pharmaceutical compositions containing S-alkylisothiouronium derivatives
11/10/1999	CN1234257A Health-care drink for delaying senility
11/09/1999	US5981540 Selective delta opioid agonists and antagonists; useful as analgesics and in treating general neurologic disorders
11/09/1999	US5981512 Means for treating radiation injuries
11/04/1999	WO1999055388A1 Substituted porphyrins
11/04/1999	WO1999055378A1 Method of treating endotoxemia
11/04/1999	WO1999055377A2 Polyol-ifn-beta conjugates
11/04/1999	WO1999055321A1 Compounds and methods for treating mitochondria-associated diseases
11/04/1999	CA2565375A1 Polyol-ifn-beta conjugates
11/04/1999	CA2330451A1 Polyol-ifn-beta conjugates
11/04/1999	CA2330033A1 Method of treating endotoxemia
11/04/1999	CA2329709A1 Compounds and methods for treating mitochondria-associated diseases
11/03/1999	EP0953049A2 Novel human metallothionein
11/03/1999	CN1233404A Health-care and pungent taste tea contg. leaves of hot spice plant
11/02/1999	US5977314 Catalytic antibodies against cocaine
10/1999
10/28/1999	WO1999053928A1 Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
10/28/1999	WO1999053920A1 Use of vitamin pp compounds
10/28/1999	WO1999053917A1 Cannabinoids as antioxidants and neuroprotectants
10/28/1999	WO1999053899A1 Medicinal compositions for application to mucosa
10/28/1999	DE19818044A1 Reducing side effects or neutralizing action of carcinostatic or immunosuppressive agents, especially pyridine derivatives, using vitamin PP compounds, e.g. nicotinamide
10/28/1999	CA2329626A1 Cannabinoids as antioxidants and neuroprotectants
10/27/1999	CN1233173A Therapeutic methods and compositions involving isoflavones
10/27/1999	CN1232817A Acetoacetarylamides
10/26/1999	US5972923 Methods and compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants
10/26/1999	CA2183320C Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
10/21/1999	DE19916896A1 Particles for chelating metal ions, useful in cosmetic, pharmaceutical and food products and products for treating liquids, especially water
10/20/1999	CN1232457A 1,4-heterocyclic metalloprotease inhibitors
10/20/1999	CN1232392A Pharmaceutical compositions comprising tyrphostins
10/20/1999	CN1045772C Polyazacycloalkanes as dichelants
10/19/1999	US5969184 Amide compounds
10/19/1999	US5968914 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
10/19/1999	US5968733 Mycobacteriophages and uses thereof
10/19/1999	US5968727 Solution for long term preservation of transplantable organs deprived of oxygen
10/19/1999	US5968520 Plant extracts from alder and mountain ash; hangover remedy
10/19/1999	US5968517 Process for extraction of proanthocyanidins from botanical material
10/13/1999	EP0948500A1 Cyclic organoselenium compounds, their preparation and their uses
10/12/1999	US5965615 Hydroxyl radical scavenger
10/12/1999	US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/07/1999	WO1999050258A1 Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof
10/06/1999	EP0946516A1 New histidine derivatives, preparation process, and their use as free antiradical agents
10/06/1999	EP0946182A1 17$g(a)-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT
10/05/1999	US5962479 Psychological and nervous sytem disorders
10/05/1999	US5962469 Cyclic nitrones
10/05/1999	US5961993 Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the treatment of acne
10/05/1999	CA2175204C Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
09/1999
09/30/1999	WO1999035246A9 Novel steroid-activated nuclear receptors and uses therefor
09/30/1999	WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
09/30/1999	DE19913864A1 DNA fragments useful for increasing p53 activity in a cell and reducing susceptibility to UV-induced hyperproliferative diseases
09/29/1999	EP0945430A2 N-phenylacetoacetamides and process for their preparation
09/29/1999	EP0944391A1 Use of equilenin as an antioxidant
09/29/1999	EP0944390A1 USE OF 17$g(b)-DIHYDROEQUILENIN AS AN ANTIOXIDANT
09/29/1999	CN1045293C Substituted pyrazoles compounds and medicinal compositions containing same
09/28/1999	US5958954 2,2-dialkyl-4-aryl-substituted benzopyran and benzothiopyran derivatives
09/28/1999	US5958373 Macrocyclic polyamine ligand forms a polychelate compound with lanthanides, chromium, iron and manganese; useful for diagnostic imaging contrast
09/22/1999	EP0772615B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
09/22/1999	EP0620741B1 Cytotoxic drug therapy
09/22/1999	CN1229131A Health-care beer added with bamboo leaf flavone extract
09/21/1999	US5955428 DNA encoding human metallothionein
09/16/1999	WO1999046242A1 Cycloalkene derivatives, process for producing the same, and use
09/16/1999	WO1999045922A1 Lipoic acid analogs
09/16/1999	WO1999045788A1 Food products having enhanced cocoa polyphenol content and processes for producing same
09/16/1999	WO1999038967A3 Recombinant proteins derived from hgf and msp
09/16/1999	CA2601285A1 Agents for use in the treatment of amyloidosis
09/16/1999	CA2320718A1 Lipoic acid analogs
09/15/1999	EP0804239B1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof

1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 191